| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |